Gå direkt till huvudinnehållet

Prematuritet, uppföljning

Senast uppdaterad: Publicerad:


  1. Horbar JD, Badger GJ, Carpenter JH et al. Trends in mortality and morbidity for very low weight infants, 1991 - 1999. Pediatrics 2002; 110: 143-51. Pediatrics  
  2. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 2006; 355: 685-94. New England Journal of Medicine  
  3. Broitman E, Ambalavanan N, Higgins RD et al. Clinical data predict neurodevelopmental outcome better than head ultrasound in extremely low birth weight infants. J Pediatr 2007; 151: 500-5. PubMed  
  4. Gross SJ , et al. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics 2005; 115: 681-7. Pediatrics  
  5. Elimian A, Garry D, Figueroa R, Spitzer A, Wiencek V, Quirk JG. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial. Obstet Gynecol 2007; 110: 26-30. PubMed  
  6. Watterberg KL, Shaffer ML, Mishefske MJ, et al. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics 2007; 120: 40-8. Pediatrics  
  7. Dsilna A, Christensson K, Alfredsson L, Lagercrantz H, Blennow M. Continuous feeding promotes gastrointestinal tolerance and growth in very low birth weight infants. J Pediatr 2005; 147: 43-9. PubMed  
  8. Shankaran S, Laptook AR, Ehrenkranz RA, et al, for the National Institute of Child Health and Human Development Neonatal Research Network. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353: 1574-84. New England Journal of Medicine  
  9. Kuschel CA, Harding JE. Protein supplementation of human milk to promote growth in preterm infants. Oxford: The Cochrane Library, issue 2, 1999. Last amendment: 11 February 1999 The Cochrane Library  
  10. Kuschel CA, Harding JE. Fat supplementation of human milk to promote growth in preterm infants. Oxford: The Cochrane Library, issue 3, 1999. Last amendment: 22 January 1999 The Cochrane Library  
  11. Kuschel CA, Harding JE. Carbohydrate supplementation of human milk to promote growth in preterm infants. Oxford: The Cochrane Library, issue 2, 1999. Last amendment: 29 November 1998 The Cochrane Library  
  12. Tubman TRJ, Thompson SW. Glutamine supplementation for prevention of morbidity in the preterm infant. Oxford: The Cochrane Library, issue 2, 1999. Last amendment: 15 February 1999 The Cochrane Library  
  13. Middleton P, Gomersall JC, Gould JF et al. Omega‐3 fatty acid addition during pregnancy. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: CD003402. DOI: 10.1002/14651858.CD003402.pub3. DOI  
  14. Nanda K, Cook LA, Gallo MF, Grimes DA. Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth (Cochrane Library). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software. The Cochrane Library  
  15. Manzoni P, Stolfi I, Pugni L et al. A multicenter, randomized trial of prophylactic fluconazole in preterm infants. N Engl J Med 2007; 356: 2483-95. New England Journal of Medicine  
  16. McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev, issue 1, 2004. The Cochrane Library  
  17. Rønnestad A, Abrahamsen TG, Medbø S et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 2005; 115: 269-76. Pediatrics  
  18. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004661. DOI: 10.1002/14651858.CD004661.pub3. DOI  
  19. Schmidt B, Asztalos EV, Roberts RS. Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months: Results From the Trial of Indomethacin Prophylaxis in Preterms. JAMA 2003; 289: 1124-9. PubMed  
  20. Wilson-Costello D, Friedman H, Minich N et al. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 2005; 115: 997-1003. Pediatrics  
  21. Wilson-Costello D, Friedman H, Minich N, et al. Improved neurodevelopmental outcomes for extremely low birth weight infants in 2000-2002. Pediatrics 2007; 119: 37-45. Pediatrics  
  22. Laptook AR , et al. Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound: prevalence and antecedents. Pediatrics 2005; 115: 673-80. Pediatrics  
  23. Shankaran S, Johnson Y, Langer JC et al. Outcome of extremely-low birth-weight infants at highest risk: gestational age <=24 weeks, birth weight <=750 g, and 1-minute Apgar <=3. Am J Obst Gynecol 2004; 191: 1084-91. PubMed  
  24. Fellman V, Hellström-Westas L, et al. One-year survival of extremely preterm infants after active perinatal care in Sweden. JAMA. 2009 Jun 3;301(21):2225-33 www.ncbi.nlm.nih.gov  
  25. Field DJ, Dorling JS, Manktelow BN, Draper ES. Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5 . BMJ 2008; 336: 1221-3. PubMed  
  • Elisabeth Olhager, med dr och överläkare, Barn- och ungdomsmedicinska kliniken, Linköping-Motala